Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q2 2013 · 10-Q
Revenue$451.00$451.00no prior Q2 2012 on file Net Income-$19.12K-$19.12KN/M vs Q2 2012 EPS Diluted$0.00$0.00— vs Q2 2012 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Operating Cash Flowderived-$14,795N/M Margins · derivedGross margin100.0%
Operating margin-3280.5%
Net margin-4239.9%
ended Jun 30, 2013 · filed Aug 15, 2013 · 46 d after period end